These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31918597)

  • 1. Rey 15 item test plus recognition trial and TOMM in a community pediatric sample.
    Teague AM; Hirst RB
    Appl Neuropsychol Child; 2020; 9(4):329-336. PubMed ID: 31918597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the Rey 15-Item Test, recognition trial, and error scores for detecting noncredible neuropsychological performance in a mixed clinical sample of veterans.
    Bailey KC; Soble JR; O'Rourke JJF
    Clin Neuropsychol; 2018 Jan; 32(1):119-131. PubMed ID: 28555516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance on the Test of Memory Malingering is predicted by the number of errors on its first 10 items on an inpatient epilepsy monitoring unit.
    Grabyan JM; Collins RL; Alverson WA; Chen DK
    Clin Neuropsychol; 2018 Apr; 32(3):468-478. PubMed ID: 28826306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing performance validity with the TOMM and automatized sequences task in a pediatric psychiatric inpatient setting.
    Weber Ku E; Oliveira JS; Cook NE; McCurdy K; Kavanaugh B; Cancilliere MK; Holler KA
    Child Neuropsychol; 2020 Aug; 26(6):801-816. PubMed ID: 31937183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO-AVLT recognition trial: Initial validation for a new malingering index for Spanish-speaking patients.
    Reyes A; LaBode-Richman V; Salinas L; Barr WB
    Appl Neuropsychol Adult; 2019; 26(6):564-572. PubMed ID: 30183353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all performance validity tests are created equal: The role of recollection and familiarity in the Test of Memory Malingering and Word Memory Test.
    Eglit GM; Lynch JK; McCaffrey RJ
    J Clin Exp Neuropsychol; 2017 Mar; 39(2):173-189. PubMed ID: 27501116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratified performance on the Test of Memory Malingering (TOMM) is associated with differential responding on the Personality Assessment Inventory (PAI).
    Whiteside DM; Hunt I; Choate A; Caraher K; Basso MR
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):131-141. PubMed ID: 31771455
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of an attention-based performance validity test for the detection of feigned cognitive dysfunction after acquired brain injury.
    Fuermaier ABM; Tucha O; Russ D; Ehrenstein JK; Stanke M; Heindorf R; Buggenthin R; Aschenbrenner S; Koerts J; Tucha L
    J Clin Exp Neuropsychol; 2020 Apr; 42(3):285-297. PubMed ID: 32041477
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of abbreviated versions of the test of memory malingering in children with traumatic brain injury.
    Donders J; Gardner V
    Appl Neuropsychol Child; 2020; 9(4):355-359. PubMed ID: 32401052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of performance and symptom validity testing with pediatric populations.
    Kirk JW; Baker DA; Kirk JJ; MacAllister WS
    Appl Neuropsychol Child; 2020; 9(4):292-306. PubMed ID: 32372667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of the Test of Memory Malingering Trial 1 in Differentiating Neurocognitive, Emotional, and Behavioral Functioning in a Pediatric Concussion Population.
    Smith A; Thomas J; Friedhoff C; Chin E
    Arch Clin Neuropsychol; 2022 Feb; 37(2):322-337. PubMed ID: 34386811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of criterion measures on the classification accuracy of TOMM-1.
    Rai JK; Erdodi LA
    Appl Neuropsychol Adult; 2021; 28(2):185-196. PubMed ID: 31187632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. They're not just little adults: The utility of adult performance validity measures in a mixed clinical pediatric sample.
    Ventura LM; DeDios-Stern S; Oh A; Soble JR
    Appl Neuropsychol Child; 2021; 10(4):297-307. PubMed ID: 31703167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification accuracy rates of four TOMM validity indices when examined independently and jointly.
    Schroeder RW; Olsen DH; Martin PK
    Clin Neuropsychol; 2019 Nov; 33(8):1373-1387. PubMed ID: 31130071
    [No Abstract]   [Full Text] [Related]  

  • 16. Using the inventory of problems - 29 (IOP-29) with the Test of Memory Malingering (TOMM) in symptom validity assessment: A study with a Portuguese sample of experimental feigners.
    Giromini L; Barbosa F; Coga G; Azeredo A; Viglione DJ; Zennaro A
    Appl Neuropsychol Adult; 2020; 27(6):504-516. PubMed ID: 30773041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury.
    Brooks BL; Sherman EMS
    Appl Neuropsychol Child; 2019; 8(4):319-325. PubMed ID: 29963927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited usefulness of the Rey Fifteen-Item Test in detection of invalid performance in veterans suspected of mild traumatic brain injury.
    Flaherty JM; Spencer RJ; Drag LL; Pangilinan PH; Bieliauskas LA
    Brain Inj; 2015; 29(13-14):1630-4. PubMed ID: 26513604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the cross-cultural validity of the test of memory malingering and the Rey 15-item test.
    Crişan I; Erdodi L
    Appl Neuropsychol Adult; 2022 Apr; ():1-11. PubMed ID: 35476611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When 10 is enough: Errors on the first 10 items of the Test of Memory Malingering (TOMMe10) and administration time predict freestanding performance validity tests (PVTs) and underperformance on memory measures.
    Denning JH
    Appl Neuropsychol Adult; 2021; 28(1):35-47. PubMed ID: 30950290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.